Home > Result Summaries: Compounds > Haemophilus influenzae Type b Vaccine > Result Summary for 111188_

Result Summary for 111188_

Result Summary

Protocol ID:	111188_
Clinical Study ID:	111188
Official Title:	Primary vaccination course in healthy children receiving the pneumococcal vaccine GSK 1024850A co-administered with Tritanrix-HepB/Hib at 6, 10 and 14 weeks of age.
Phase:	phase 3
Study Indications or Diseases:	Hib
Generic Name:	Haemophilus influenzae Type b Vaccine
Trade/Product Name:	Hiberix
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Lalwani S et al. Immunogenicity and safety profile of a 3-dose primary vaccination with pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine in Indian infants. Abstract presented at the 48th National Conference of Indian Academy of Pediatrics (Pedicon). Jaipur, India, 19-23 January 2011. Lalwani S et al. (2012) Immunogenicity, safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when co-administered with the DTPw-HBV/Hib vaccine in Indian infants: a single-blind, randomised, controlled study. Hum Vaccin Immunother. 8(5):613-623.